IP Library Granted Patent US 11,272,982
Granted Patent B2
US 11,272,982 · App. 16/511,947 · Granted Mar 15, 2022

Intravascular treatment catheters

Inventors: Hanson Gifford, III (Woodside, CA); Mark E. Deem (Mountain View, CA); Stephen Boyd (Murrieta, CA)
Assignee: Twelve, Inc.
A61B18/1492A61B17/221A61B17/2202A61B17/22012A61B17/320758A61B18/02A61F2/2445A61M25/04A61N7/022A61B8/12A61B18/18A61B2017/2215A61B2017/22038A61B2017/22061A61B2017/22069A61B2017/22079A61B2017/22098A61B2018/00011A61B2018/0022A61B2018/0262A61M2025/105A61N2007/0039
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,272,982
App. No.
16/511,947
Granted
Mar 15, 2022
Kind
B2
Abstract

The present invention provides devices and methods for decalcifying an aortic valve. The methods and devices of the present invention break up or obliterate calcific deposits in and around the aortic valve through application or removal of heat energy from the calcific deposits.

Claims (15)

1. A method comprising:

advancing a catheter within vasculature of a patient to a treatment site within a body lumen of the patient;

deploying an expandable distal basket from the catheter, wherein the expandable distal basket comprises a plurality of elongate members, and wherein removing the expandable distal basket from the catheter allows the expandable distal basket to transform from a low-profile delivery configuration to an expanded deployed configuration in which one or more elongate members of the plurality of elongate members contact a wall of the body lumen, wherein the plurality of elongate members comprise a plurality of electrodes arranged along the plurality of elongate members, wherein the plurality of electrodes are configured to be positioned in contact with the wall of the body lumen when the distal basket is in the expanded deployed configuration, and wherein at least two of the electrodes are at different longitudinal positions along the distal basket;

delivering energy to generate an electric field to target tissue adjacent the body lumen using the plurality of electrodes; and

delivering a pharmaceutical agent into the body lumen through a plurality of infusion ports or outlets, wherein the plurality of infusion ports or outlets are distributed along at least one elongate member of the plurality of elongate members and are interspersed among and distinct from the plurality of electrodes.

2. The method of claim 1 , wherein the plurality of elongate members are fabricated from shape-memory material.

3. The method of claim 1 , wherein the plurality of elongate members comprise a metal.

4. The method of claim 1 , wherein the plurality of elongate members comprise a plastic.

5. The method of claim 1 , wherein the expandable distal basket is configured to self-expand upon being removed from the catheter.

6. The method of claim 1 , further comprising mechanically actuating the expandable distal basket from the low-profile delivery configuration to the expanded deployed configuration after removing the expandable distal basket from the catheter.

7. The method of claim 1 , wherein the plurality of electrodes are arranged in a staggered configuration along the plurality of elongate members, and wherein delivering the electric field comprises selectively energizing a subset of the plurality of electrodes to produce a selected treatment electric field.

8. The method of claim 1 , wherein delivering energy to generate the electric field comprises delivering a non-pulsed thermal RF electric field.

9. The method of claim 1 , wherein delivering energy to generate the electric field comprises delivering a pulsed electric field.

10. The method of claim 1 , wherein a plurality of electrodes are carried by each elongate member.

11. The method of claim 1 , wherein the plurality of infusion ports or outlets are configured to allow infusion of the pharmaceutical agent before, during, and/or after delivering the electric field.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2019
From: GIFFORD, HANSON; DEEM, MARK E.; BOYD, STEPHEN
To: THE FOUNDRY, INC.
Reel/Frame 049756/0009 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2019
From: THE FOUNDRY, INC.
To: THE FOUNDRY, LLC
Reel/Frame 049756/0045 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2019
From: THE FOUNDRY, LLC
To: FOUNDRY NEWCO XII, INC.
Reel/Frame 049756/0143 →
CHANGE OF NAME Recorded Jul 15, 2019
From: FOUNDRY NEWCO XII, INC.
To: TWELVE, INC.
Reel/Frame 049758/0702 →
Continuity (8)
Continuation 15212797 · Jul 18, 2016
Continuation 13692613 · Dec 3, 2012
Continuation 12870270 · Aug 27, 2010
Division 11299246 · Dec 9, 2005
Provisional Application 60635275 · Dec 9, 2004
Provisional Application 60662764 · Mar 16, 2005
Provisional Application 60698297 · Jul 11, 2005
Related Publication 20190350651A1 · Nov 21, 2019